Products comprising inactivated yeasts or moulds and active VHH-type antibodies
US8951755B1 · kind B1 · utility
0Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1999 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Mar 12, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of VHHs in the preparation of products to provide stability of antibody specificity under destabilizing conditions whereby normally lower eukaryotes or traditional antibodies are killed or inactivated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.